PAHC FY 2021 Earnings Report — Phibro Animal Health Corporation Revenue & Financial Results | Market Cap Arena

Phibro Animal Health CorporationPAHC

FY 2021 Earnings

Reported August 25, 2021

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2021	Prior Q	FY 2020	QoQ Change	YoY Change
Revenue	$833M	—	$800M	—	4.1%
Op. Income	$75M	—	$69M	—	8.2%
Gross Margin	32.6%	—	32.1%	—	0.5pp
Net Margin	6.5%	—	4.2%	—	2.3pp
EPS (Diluted)	$1.34	—	$0.83	—	61.4%
Free Cash Flow	$19M	—	$25M	—	-25.0%

Revenue Flow

Item	Amount
REVENUE	$833M
Cost of Revenue	$562M
GROSS PROFIT	$271M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$197M
Other Expenses	$0
Operating Expenses	$197M
Cost & Expenses	$758M
OPERATING INCOME	$75M
Interest Income	$838.0K
Interest Expense	$10M
Other Income/Expenses	-$8M
INCOME BEFORE TAX	$66M
Income Tax Expense	$12M
Net Income from Continuing Ops	$54M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$54M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$54M
D&A	$32M
EBIT	$78M
EBITDA	$110M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$833M
Cost of Revenue	$562M
GROSS PROFIT	$271M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$197M
Other Expenses	$0
Operating Expenses	$197M
Cost & Expenses	$758M
OPERATING INCOME	$75M
Interest Income	$838.0K
Interest Expense	$10M
Other Income/Expenses	-$8M
INCOME BEFORE TAX	$66M
Income Tax Expense	$12M
Net Income from Continuing Ops	$54M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$54M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$54M
D&A	$32M
EBIT	$78M
EBITDA	$110M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$54M
Depreciation & Amortization	$32M
Stock-Based Compensation	$1M
Deferred Income Tax	-$2M
Other Non-Cash Items	-$7M
Change in Working Capital	-$30M
OPERATING CASH FLOW	$48M
Capital Expenditure	-$29M
Acquisitions (Net)	$29M
Purchases of Investments	-$74M
Sales/Maturities of Investments	$86M
Other Investing Activities	-$31M
NET CASH FROM INVESTING	-$19M
Net Debt Issuance	$5M
Common Stock Repurchased	$0
Common Dividends Paid	-$19M
Other Financing Activities	-$3M
NET CASH FROM FINANCING	-$17M
FREE CASH FLOW	$19M
Net Change in Cash	$14M

Balance Sheet

Item	Amount
Cash & Equivalents	$50M
Short-Term Investments	$43M
Net Receivables	$147M
Inventory	$216M
Other Current Assets	$43M
TOTAL CURRENT ASSETS	$499M
PP&E (Net)	$188M
Goodwill	$53M
Intangible Assets	$62M
Long-Term Investments	$10M
Tax Assets	$10M
Other Non-Current Assets	$20M
TOTAL NON-CURRENT ASSETS	$342M
TOTAL ASSETS	$841M
Account Payables	$68M
Short-Term Debt	$9M
Deferred Revenue	$0
Other Current Liabilities	$56M
TOTAL CURRENT LIABILITIES	$164M
Long-Term Debt	$383M
Deferred Revenue NC	$0
Deferred Tax Liabilities	$7M
Other Non-Current Liabilities	$21M
TOTAL NON-CURRENT LIABILITIES	$439M
TOTAL LIABILITIES	$603M
Common Stock	$4.0K
Additional Paid-In Capital	$136M
Retained Earnings	$218M
Treasury Stock	$0
Accum. Other Comp. Income	-$115M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$239M
Minority Interest	$0
TOTAL EQUITY	$239M
TOTAL LIABILITIES & EQUITY	$841M
Total Debt	$427M
Net Debt	$376M